|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4) the device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents reported from this lot.The investigation was unable to determine a conclusive cause for the stent malapposition; however the treatment appears to be related to circumstances of the procedure.It should be noted the xience alpine everolimus eluting coronary stent system electronic instructions for use states: the xience alpine stent system is indicated for improving coronary artery luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease due to de novo native coronary artery lesions.Based on the information reviewed, there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.The other xience alpine device referenced in describe event or problem and concomitant medical products is filed under a separate medwatch report.
|